Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 5/20 | 0.51 |
| ▸ | THRA | P10827 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | PDE6D | O43924 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | AKT1 | P31749 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL2818434 | 0.98 | THRB (0.50) | THRBTHRAMAPTZDHHC2PDE6D | |
| Ether SCHEMBL6578176 | 0.98 | THRB (0.50) | THRBTHRAMAPTZDHHC2PDE6D | |
| Ether SCHEMBL2362844 | 0.95 | THRB (0.48) | THRBTHRAMAPTZDHHC2PDE6D | |
| Ether SCHEMBL1246730 | 0.95 | THRB (0.56) | THRBTHRAMAPTZDHHC2PDE6D | |
| 1,6-Hexanediol SCHEMBL23069547 | 0.93 | THRB (0.46) | THRBTHRAMAPTZDHHC2PDE6D | |
| Di(Hydroxyethyl)Ether SCHEMBL2345984 | 0.92 | THRB (0.48) | THRBTHRAMAPTZDHHC2PDE6D | |
| Triethylene Glycol SCHEMBL7896473 | 0.91 | THRB (0.47) | THRBTHRAMAPTZDHHC2PDE6D | |
| Tetraethylene Glycol SCHEMBL18092769 | 0.91 | THRB (0.47) | THRBTHRAMAPTZDHHC2PDE6D | |
| Ethylene Glycol SCHEMBL2694080 | 0.90 | THRB (0.56) | THRBTHRAPDE6DSMN1; SMN2TGM2 | |
| Diethylene Glycol Monoethyl Ether SCHEMBL1508669 | 0.88 | THRB (0.47) | THRBTHRAMAPTZDHHC2PDE6D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042870-A1 | BINDER COMPOSITIONS AND USES THEREOF | KNAUF INSULATION SPRL (BE) | 2026-02-12 | — | — | US | claimed |
| US-12492275-B2 | Photo-curable compositions containing high refractive index monomers for use in 3D printing applications | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | claimed |
| WO-2025198684-A9 | BaTiO3 NANOCRYSTALS AND NANOCOMPOSITES | PIXELLIGENT TECHNOLOGIES LLC (US) | 2025-11-27 | — | — | WO | claimed |
| US-12466899-B2 | Binder compositions and uses thereof | KNAUF INSULATION SPRL (BE) | 2025-11-11 | — | — | US | claimed |
| WO-2025215466-A1 | ACRYLATE BASED MATRIX LIQUID CRYSTALS NCAP | ORBOTECH LTD (IL) | 2025-10-16 | — | — | WO | claimed |
| US-20250314923-A1 | ACRYLATE BASED MATRIX LIQUID CRYSTALS NCAP | ORBOTECH LTD. (IL) | 2025-10-09 | — | — | US | claimed |
| US-12427714-B2 | Functionalized product fabricated from a resin comprising a functional component and a polymeric resin, and method of making the same | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2025-09-30 | — | — | US | claimed |
| EP-4590766-A1 | PHOTORESIN FORMULATIONS AND USE THEREOF FOR VOLUMETRIC ADDITIVE MANUFACTURING | National Research Council of Canada (CA) | 2025-07-30 | — | — | EP | claimed |
| US-20250230334-A1 | SOLVENT-FREE FORMULATIONS AND NANOCOMPOSITES | PT SPE SUBCO LLC (US) | 2025-07-17 | — | — | US | claimed |
| US-20250198980-A1 | COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2025-06-19 | — | — | US | claimed |
| US-20010050031-A1 | Compositions for three-dimensional printing of solid objects | Z CORPORATION (US) | 2001-12-13 | — | — | US | claimed |
| WO-2001078969-A2 | COMPOSITIONS FOR THREE-DIMENSIONAL PRINTING OF SOLID OBJECTS | Z CORPORATION (US) | 2001-10-25 | — | — | WO | claimed |
| US-6300391-B2 | FAST DRYING; CONTROLLED BLEEDING AND HALO | HEWLETT-PACKARD COMPANY | 2001-10-09 | — | — | US | claimed |
| US-20010018472-A1 | INKS CONTAINING GLYCOL ETHERS AND SPECIFIC POLYMERS FOR DRY TIME AND BLEED IMPROVEMENTS IN INK-JET PRINTING INKS | HEWLETT-PACKARD COMPANY | 2001-08-30 | — | — | US | claimed |
| US-6281319-B1 | HYDRATABLE POLYMER | SURGIDEV CORPORATION | 2001-08-28 | — | — | US | claimed |
| US-6281267-B2 | CONTAINING PH-SENSITIVE POLYMER | HEWLETT-PACKARD COMPANY | 2001-08-28 | — | — | US | claimed |
| US-20010008908-A1 | INK TO INK BLEED AND HALO CONTROL USING SPECIFIC POLYMERS IN INK-JET PRINTING INKS | HEWLETT-PACKARD COMPANY | 2001-07-19 | — | — | US | claimed |
| EP-1088866-A1 | Inks containing glycol ethers and specific polymers for dry time and bleed improvements in ink-jet printing inks | Hewlett-Packard Company (US) | 2001-04-04 | — | — | EP | claimed |
| WO-2000061646-A1 | WATER PLASTICIZED HIGH REFRACTIVE INDEX POLYMER FOR OPHTHALMIC APPLICATIONS | SURGIDEV CORPORATION (US) | 2000-10-19 | — | — | WO | claimed |
| EP-0997506-A1 | Ink to ink bleed and halo control using specific polymers in ink-jet printing inks | Hewlett-Packard Company (US) | 2000-05-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042870-A1 | BINDER COMPOSITIONS AND USES THEREOF | SMCHD1, VCL, FGB | THRB 3507/4885THRA 3647/4885MAPT 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.